---
document_datetime: 2023-09-21 18:19:07
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/fablyn-epar-all-authorised-presentations_en.pdf
document_name: fablyn-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9402946
conversion_datetime: 2025-12-20 01:54:37.883101
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU number       | Invented name   | Strength   | Pharmaceutical Form   | Route of administration   | Packaging            | Package size   |
|-----------------|-----------------|------------|-----------------------|---------------------------|----------------------|----------------|
| EU/1/08/500/001 | FABLYN          | 500 μ g    | Film-coated tablet    | Oral use                  | Blister (PV/PVC/alu) | 7 tablets      |
| EU/1/08/500/002 | FABLYN          | 500 μ g    | Film-coated tablet    | Oral use                  | Blister (PV/PVC/alu) | 28 tablets     |
| EU/1/08/500/003 | FABLYN          | 500 μ g    | Film-coated tablet    | Oral use                  | Blister (PV/PVC/alu) | 30 tablets     |
| EU/1/08/500/004 | FABLYN          | 500 μ g    | Film-coated tablet    | Oral use                  | Bottle (HDPE)        | 90 tablets     |

<!-- image -->